Apotex Seeks To Maintain 156 Days Of Exclusivity For Generic Plavix
This article was originally published in The Pink Sheet Daily
Executive Summary
Apotex petitions FDA to stay action on other clopidogrel ANDAs, as Dr. Reddy’s gets into position for a generic launch.